Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study-Reference-Cited by-同舟云学术

Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study

Published:2022-08-03 Issue:3 Volume:22 Page:245-252
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Chiricozzi Andrea^ORCID,Gori Niccolò,Narcisi Alessandra,Balato Anna,Gambardella Alessio,Ortoncelli Michela,Marzano Angelo Valerio,Balestri Riccardo,Palazzo Giovanni,Pellegrino Michele,Romanelli Marco,Tripepi Giovanni,Peris Ketty,Costanzo Antonio,Bertoldi Alberto Maria,Fabbrocini Gabriella,Fargnoli Maria Concetta,Girolomoni Giampiero,Parodi Aurora,Quaglino Pietro,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-022-00396-1.pdf

Reference30 articles.

1. Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4:1.

2. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73:1284–93.

3. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32:657–82.

4. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–78.

5. Simpson EL, Bieber T, Guttman-Yassky E, et al. Two Phase 3 trials of dupilumab versus placebo in AD. N Engl J Med. 2016;375:2335–48.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Encompassing Review on Therapeutic Targets, Therapies and Nanostructure Based Formulations for Atopic Dermatitis;International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN);2024-08-15

2. Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study;Actas Dermo-Sifiliográficas;2024-06

3. [Artículo traducido] Experiencia en práctica clínica real con upadacitinib en adolescentes y adultos con dermatitis atópica refractaria: un estudio retrospectivo de 24 semanas;Actas Dermo-Sifiliográficas;2024-06

4. Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus;Dermatology and Therapy;2024-03-21

5. Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review;Clinical, Cosmetic and Investigational Dermatology;2024-03